Alisa Lee Sherick MD
University of Colorado Denver
Targeting MerTK as an immunotherapeutic strategy in pediatric acute myeloid leukemia
Mirian Rosenberg, PhD
Hebrew University of Jerusalem/ The Children's Hospital of Philadelphia
Autoantigen discovery and immune profiling of Opsoclonus Myoclonus Syndrome
Eunice Lopez Fuentes, Ph.D
University of California, San Francisco
Novel combination therapies to target metastatic osteosarcoma based on epigenetic analysis of chromatin accessibility
Funded in Partnership with The Burns Family
Shahrzad Bahrampour , Ph.D
The Hospital for Sick Children, Toronto
Unconventional role of volume-regulated anion channel in pediatric brain tumor
Funded by #ColbyStrong
Aasef G. Shaikh MD,PhD
Functional Electrical Stimulation Institute
Membranes and Models - Towards Targeted Therapy of Opsoclonus
Funded in partnership with The Viswanatha Family + Friends
Inga-Marie Schaefer, MD
Brigham and Women's Hospital
CIC-rearranged sarcoma: biologic mechanisms and therapeutic targeting
Funded in Partnership with #ColbyStrong
Patricia Denise B. Tiburcio, PhD
University of Texas, Southwestern
Targeting Proteasome and mTOR pathways in Actinomycin-Resistant Wilms Tumors
Funded by Funded by Gentleman Toker In Honor of Michelle Laderman
Delfim Duarte, MD PhD
Instituto de Investigação e Inovação em Saúde da Universidade do Porto, Portugal
Cell competition as a mechanism to eliminate minimal residual disease in acute myeloid leukemia
Amy Erbe-Gurel, PhD
University of Wisconsin
Improving Specific Targeting of Neuroblastoma Tumors through Bispecific SNIPER Antibody to Reduce Off-Target Toxicities
Dung-Fang Lee, PhD
The University of Texas Health Science Center
The Epitranscriptomic Pathway is a Therapeutic Vulnerability in p53-mutant Osteosarcoma
Vicki Huff, PhD
University of Texas M.D. Anderson Cancer Center
Assessment of a cancer preventive agent for Wilms tumor
Thais Armangue, MD, PhD
Institute for Biomedical Research August Pi i Sunyer-Barcelona, Spain
Opsoclonus myoclonus syndrome: a novel approach to antigen identification and disease modeling
Grant Funded in Partnership with The Viswanatha Family + Friends
Julien Fleurence PhD, PharmD
Baylor College of Medicine
T cells expressing a next-generation glypican-3-specific CAR incorporating IL-7 receptor signaling to cure pediatric liver cancers
Lai Man (Natalie) Wu , PhD
Cincinnati Children’s Hospital Medical Center
Identification of cellular diversity and tumor-initiating cells driving NF-to-MPNST and drug resistance by single-cell multiomics for targeted therapy
Supported in part by Hanna's Hoops 4 Healing
Alexandra Stevens, MD, PhD
Baylor College of Medicine
Predicting Atovaquone-Induced Apoptosis in Pediatric AML
Grant Rowe, MD PhD
Children’s Hospital Boston
Targeting leukemia stem cells in infant B-lymphoblastic leukemia
This grant is funded by Change a Life Foundation
Laura Perin, PhD
Children's Hospital Los Angeles
Cancer Stem Cells in Wilms Tumor: Can the Self-Renewal State Be Pushed to Nephrogenesis?
Surinder Kumar, PhD
University of Michigan
The sirtuin SIRT5 as a novel therapeutic target for Ewing's Sarcoma
This grant is funded by Peloton Magazine